Indianapolis, IN, United States of America

Ronald K Knickerbocker

This inventor holds 1 USPTO granted patent. Top assignee: Eli Lilly and Company. Active years: 2001.


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2001

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Ronald K. Knickerbocker

Introduction

Ronald K. Knickerbocker is a notable inventor based in Indianapolis, IN (US). He has made significant contributions to the field of medicine, particularly in cancer prevention. His work has the potential to impact many lives through innovative approaches to health care.

Latest Patents

Knickerbocker holds a patent for "Methods of preventing breast cancer." This patent describes a method of preventing breast cancer by administering an effective amount of a specific compound to individuals in need. His innovative approach highlights the importance of research in developing preventive measures against serious health issues.

Career Highlights

Throughout his career, Ronald K. Knickerbocker has been associated with Eli Lilly and Company, a leading pharmaceutical company. His work there has allowed him to focus on groundbreaking research and development in the medical field. His dedication to innovation is evident in his patent and ongoing contributions to cancer prevention.

Collaborations

Knickerbocker has collaborated with esteemed colleagues such as Joan E. Glusman and Fredric Jay Cohen. These partnerships have fostered an environment of creativity and innovation, leading to advancements in their respective fields.

Conclusion

Ronald K. Knickerbocker's contributions to cancer prevention through his patent and work at Eli Lilly and Company exemplify the impact of dedicated inventors in the medical field. His innovative methods hold promise for improving health outcomes and advancing research in cancer prevention.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…